# Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers

> **NCT02119754** · PHASE2 · COMPLETED · sponsor: **PluroGen Therapeutics, Inc** · enrollment: 15 (actual)

## Conditions studied

- Diabetic Foot Ulcer
- Infection

## Interventions

- **DRUG:** Plurogel PN

## Key facts

- **NCT ID:** NCT02119754
- **Lead sponsor:** PluroGen Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02119754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02119754, "Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02119754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*